Since our formation in 2017, we have invested over £11 million in a targeted portfolio of MND research to expedite the development of new treatments.
We support innovative projects across all three of the strategic priorities in our research strategy.
Our investments cover lab-based “pre-clinical” research, through to clinical studies to test the most promising treatments in people living with MND.
Click on a research project below to read more information. Filter to narrow by different strategic priorities.
Last updated January 2024
We’ve produced these handy infographics that explain the research we are currently funding without using lengthy scientific words. Click on a picture to hear more about the project. We are always updating this page with new research so please keep checking back.